AAFCPAs Wealth Management »

Acrivon Therapeutics shares owned by AAFCPAs Wealth Management

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by AAFCPAs Wealth Management from 13F filings

Historical chart of AAFCPAs Wealth Management investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by AAFCPAs Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by AAFCPAs Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $53k 11k 4.92
2023-09-30 $102k 11k 9.56
2023-06-30 $138k 11k 12.96

More positions owned by AAFCPAs Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Intl (IDEV)
Vanguard Index Fds Value Etf (VTV)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Whitehall Fds Intl High Etf (VYMI)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Mid Cap Etf (VO)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl C (GOOG)
Fidelity Covington Trust Enhanced Large (FELC)
Ishares Tr Msci Emg Mkt Etf (EEM)
Invesco Exchange Traded Fd T Intl Divi Achi (PID)

View all positions for AAFCPAs Wealth Management

Top funds holding Acrivon Therapeutics

RA Capital Management
Perceptive Advisors
Citadel Advisors
Wellington Management Company
Marshall Wace
Vanguard Group
NEA Management Company
Federated Investors
DAFNA Capital Management
Charles Schwab Investment Management
Exchange Traded Concepts
Jacobs Levy Equity Management
Jpmorgan Chase & Co
D. E. Shaw & Co
Barclays

View all funds holding Acrivon Therapeutics